Name: Lirilumab
Brand: TargetMol
SKU: T77423
Price: 2320 CNY
Availability: InStock
Rating: 5 (10 reviews)

规格

价格

库存

数量

1 mg

¥ 2,320

现货

5 mg

¥ 5,490

现货

10 mg

¥ 7,480

现货

25 mg

¥ 10,900

现货

50 mg

¥ 14,800

现货

生物活性

产品描述	Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-κB deinhibition. It can be used to study leukemia, head and neck squamous cell carcinoma (SCCHN).
体内活性	使用Lirilumab（静脉注射；一次；15 mg/kg）治疗能够提高被注射肿瘤的小鼠的存活率[1]。
表达系统	CHO
别名	利瑞鲁单抗, ONO-4483, IPH2102
反应种属	Human
验证活性	Immobilized Human KIR2DL1 Protein (His) (TMPY-02629) at 2 μg/mL (100 μL/well) can bind Lirilumab. The EC50 is 3.92 ng/mL.
应用	ELISA FCM Functional assay
抗体种类	Monoclonal
缓冲液	Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
内毒素	<1.0 EU/mg

抗体信息

同型	Human IgG4SP kappa
推荐同型对照	Human IgG4 (S228P) kappa, Isotype Control

偶联与修饰

偶联	Unconjugated

抗原信息

化学信息

分子量	145.52 kDa
CAS No.	1000676-41-4

储存&溶解度

存储	-20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准

Lirilumab